❌

Normal view

Received — 10 September 2026 ⏭ Nature Cancer

Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

✇Nature Cancer
By: Elizabeth A. R. Garfinkle · Renzo Perales-Linares · Ryan C. Gimple · Alexandra J. Livingstone · Kaleigh F. Roberts · Omar H. Butt · S. Peter Goedegebuure · Michael D. McLellan · Gue Su Chang · Jasreet Hundal · Jian Yan · Jaye B. Navarro · Sophia A. Paxton · Srestha Chattopadhyay · Neil Cooch · Alfredo Perales-Puchalt · Konstantina Stavroulaki · Sarah Rochestie · Joann Peters · Beth Junker · Jian L. Campian · Milan G. Chheda · Michael R. Chicoine · Albert H. Kim · Jon T. Willie · Gregory J. Zipfel · Joshua L. Dowling · Christopher A. Miller · Obi L. Griffith · Malachi Griffith · William E. Gillanders · Katherine E. Miller · Elaine R. Mardis · Niranjan Y. Sardesai · Gavin P. Dunn · Tanner M. Johanns
1 September 2026 at 08:00

Nature Cancer, Published online: 01 September 2026; doi:10.1038/s43018-026-01243-x

Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
There are no more articles
❌